CareDx Announces First Quarter 2026 Financial Results
CareDx reported Q1 2026 revenue of $118 million, up 39% year-over-year, driven by a 48% increase in testing services revenue to $91 million. The company raised its full-year 2026 revenue guidance to $447M-$465M and AEBITDA guidance to $43M-$57M, signaling strong momentum.
Key figures
- Eps
- 0.05
- Guidance
- FY26 revenue $447M-$465M, raised from $420M-$444M; FY26 AEBITDA $43M-$57M
- Revenue Yoy
- 39%
- Deal Value Usd
- 170000000
- Testing volume
- 54900
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.